(20S)-ginsenoside Rg3 multiple interactions ISO RGD:2206 6480464 ginsenoside Rg3 inhibits the reaction [Dexamethasone results in decreased expression of BGLAP protein] CTD PMID:27387537 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of BGLAP CTD PMID:19436947 (S)-nicotine decreases expression ISO RGD:2206 6480464 Nicotine results in decreased expression of BGLAP mRNA CTD PMID:29981921 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of BGLAP CTD PMID:19436947 (S)-nicotine multiple interactions EXP 6480464 Tubocurarine inhibits the reaction [Nicotine results in increased expression of BGLAP] CTD PMID:19436947 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:1621634 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:30529163 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression ISO RGD:1621634 6480464 15-deoxy-delta12, 14-prostaglandin J2 results in decreased expression of BGLAP mRNA CTD PMID:12021203 17alpha-ethynylestradiol multiple interactions EXP 6480464 VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 17alpha-ethynylestradiol affects expression ISO RGD:2206 6480464 Ethinyl Estradiol affects the expression of BGLAP protein CTD PMID:11861784 , PMID:15261309 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with ESR1 protein] results in increased expression of BGLAP mRNA more ... CTD PMID:17689939 , PMID:19347870 17beta-estradiol decreases expression ISO RGD:2206 6480464 Estradiol results in decreased expression of BGLAP protein CTD PMID:15917159 , PMID:15979666 17beta-estradiol increases expression ISO RGD:2206 6480464 Estradiol results in increased expression of BGLAP mRNA CTD PMID:16964405 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of BGLAP mRNA CTD PMID:17689939 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression EXP 6480464 Metribolone results in increased expression of BGLAP mRNA CTD PMID:19759027 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1621634 6480464 Dihydrotestosterone results in increased expression of BGLAP mRNA CTD PMID:17898587 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one decreases expression EXP 6480464 1H-1 more ... CTD PMID:22543296 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:1621634 6480464 2 more ... CTD PMID:25795401 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1621634 6480464 Tetrachlorodibenzodioxin results in decreased expression of BGLAP, Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA CTD PMID:19264158 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BGLAP mRNA, Tetrachlorodibenzodioxin affects the expression of BGLAP protein CTD PMID:30203000 , PMID:31887333 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1621634 6480464 Tetrachlorodibenzodioxin affects the expression of BGLAP mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1621634 6480464 AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA] more ... CTD PMID:19264158 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2206 6480464 Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA CTD PMID:19201780 , PMID:19264158 2,3-bisphospho-D-glyceric acid decreases activity EXP 6480464 2, 3-Diphosphoglycerate results in decreased activity of BGLAP protein CTD PMID:16857255 2,3-bisphosphoglyceric acid decreases activity EXP 6480464 2, 3-Diphosphoglycerate results in decreased activity of BGLAP protein CTD PMID:16857255 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO RGD:1621634 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of BGLAP protein CTD PMID:23747339 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine analog results in increased expression of BGLAP mRNA CTD PMID:20458730 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression ISO RGD:2206 6480464 Puromycin Aminonucleoside results in increased expression of BGLAP protein CTD PMID:9154658 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:2206 6480464 3 more ... CTD PMID:31820026 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of BGLAP mRNA CTD PMID:31326446 3-aminobenzamide increases expression EXP 6480464 3-aminobenzamide results in increased expression of BGLAP mRNA CTD PMID:15670817 4',5,7-trihydroxy-3'-methoxyflavone multiple interactions ISO RGD:1621634 6480464 chrysoeriol inhibits the reaction [Hydrogen Peroxide results in decreased expression of BGLAP protein] CTD PMID:20981859 5-(1,4-diazepane-1-sulfonyl)isoquinoline multiple interactions ISO RGD:1621634 6480464 4-4-fluorophenyl-2-4-hydroxyphenyl-5-4-pyridylimidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP mRNA] more ... CTD PMID:31935364 5-azacytidine decreases expression ISO RGD:2206 6480464 Azacitidine results in decreased expression of BGLAP protein CTD PMID:18037191 5-fluorouracil increases expression ISO RGD:2206 6480464 Fluorouracil results in increased expression of BGLAP mRNA CTD PMID:16888818 5-formyltetrahydrofolic acid multiple interactions ISO RGD:2206 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of BGLAP mRNA CTD PMID:25187349 6-propyl-2-thiouracil decreases expression ISO RGD:2206 6480464 Propylthiouracil results in decreased expression of BGLAP mRNA CTD PMID:24780913 6alpha-methylprednisolone decreases secretion ISO RGD:2206 6480464 Methylprednisolone results in decreased secretion of BGLAP protein CTD PMID:30291735 6alpha-methylprednisolone multiple interactions ISO RGD:2206 6480464 [Nebivolol co-treated with Alendronate] inhibits the reaction [Methylprednisolone results in decreased secretion of BGLAP protein] CTD PMID:30291735 9-cis-retinoic acid decreases expression EXP 6480464 Alitretinoin results in decreased expression of BGLAP mRNA CTD PMID:12898515 9-cis-retinoic acid decreases expression ISO RGD:1621634 6480464 Alitretinoin results in decreased expression of BGLAP mRNA CTD PMID:16392701 9-cis-retinoic acid multiple interactions EXP 6480464 [Calcitriol co-treated with Alitretinoin] results in increased expression of BGLAP mRNA more ... CTD PMID:12898515 acrylamide decreases expression ISO RGD:2206 6480464 Acrylamide results in decreased expression of BGLAP mRNA CTD PMID:22197712 aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine analog results in increased expression of BGLAP mRNA CTD PMID:20458730 alendronic acid multiple interactions ISO RGD:2206 6480464 [Nebivolol co-treated with Alendronate] inhibits the reaction [Methylprednisolone results in decreased secretion of BGLAP protein] CTD PMID:30291735 all-trans-retinoic acid multiple interactions ISO RGD:1621634 6480464 [Tretinoin co-treated with Cholecalciferol] results in increased expression of BGLAP, Tretinoin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA] CTD PMID:17170073 , PMID:32473317 all-trans-retinoic acid increases expression ISO RGD:1621634 6480464 Tretinoin results in increased expression of BGLAP mRNA CTD PMID:16889531 all-trans-retinoic acid decreases expression ISO RGD:1621634 6480464 Tretinoin results in decreased expression of BGLAP mRNA CTD PMID:16350840 , PMID:16392701 allethrin multiple interactions ISO RGD:1621634 6480464 Allethrins inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA] CTD PMID:32473317 allopurinol increases expression ISO RGD:2206 6480464 Allopurinol results in increased expression of BGLAP mRNA CTD PMID:26968635 alloxanthine increases expression ISO RGD:2206 6480464 Oxypurinol results in increased expression of BGLAP mRNA CTD PMID:26968635 aluminium atom multiple interactions ISO RGD:2206 6480464 Aluminum inhibits the reaction [Calcitriol results in increased secretion of BGLAP protein], Calcitriol inhibits the reaction [Aluminum results in decreased secretion of BGLAP protein] CTD PMID:9626627 aluminium atom decreases secretion ISO RGD:2206 6480464 Aluminum results in decreased secretion of BGLAP protein CTD PMID:9626627 aluminium oxide increases expression EXP 6480464 Aluminum Oxide results in increased expression of BGLAP mRNA CTD PMID:19464052 aluminium(0) decreases secretion ISO RGD:2206 6480464 Aluminum results in decreased secretion of BGLAP protein CTD PMID:9626627 aluminium(0) multiple interactions ISO RGD:2206 6480464 Aluminum inhibits the reaction [Calcitriol results in increased secretion of BGLAP protein], Calcitriol inhibits the reaction [Aluminum results in decreased secretion of BGLAP protein] CTD PMID:9626627 ammonium chloride affects expression ISO RGD:2206 6480464 Ammonium Chloride affects the expression of BGLAP mRNA CTD PMID:16483693 ammonium chloride multiple interactions EXP 6480464 Ammonium Chloride inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA] CTD PMID:23111315 amphetamine increases expression ISO RGD:2206 6480464 Amphetamine results in increased expression of BGLAP mRNA CTD PMID:30779732 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:2206 6480464 [pyrazolanthrone co-treated with SB 203580 co-treated with 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one] inhibits the reaction [Quercetin results in increased expression of BGLAP protein], pyrazolanthrone inhibits the reaction [Quercetin results in increased expression of BGLAP protein] CTD PMID:26136938 antimycin A multiple interactions ISO RGD:1621634 6480464 sciadopitysin inhibits the reaction [Antimycin A results in increased expression of BGLAP protein] CTD PMID:23624148 antimycin A increases expression ISO RGD:1621634 6480464 Antimycin A results in increased expression of BGLAP protein CTD PMID:23624148 apocynin multiple interactions ISO RGD:2206 6480464 acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of BGLAP mRNA] CTD PMID:24080574 Aroclor 1254 decreases expression ISO RGD:1621634 6480464 Chlorodiphenyl 54% Chlorine results in decreased expression of BGLAP mRNA CTD PMID:25795401 arsenous acid decreases expression ISO RGD:2206 6480464 Arsenic Trioxide results in decreased expression of BGLAP, Arsenic Trioxide results in decreased expression of BGLAP mRNA CTD PMID:22465848 , PMID:24531206 arsenous acid multiple interactions ISO RGD:2206 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in decreased expression of BGLAP] CTD PMID:24531206 atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of BGLAP mRNA CTD PMID:17252541 aucubin increases expression EXP 6480464 aucubin results in increased expression of BGLAP protein CTD PMID:29408431 azadirachtin A multiple interactions ISO RGD:1621634 6480464 azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of BGLAP protein] CTD PMID:31225646 bafilomycin A1 multiple interactions EXP 6480464 bafilomycin A1 inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA] CTD PMID:23111315 beclomethasone decreases expression EXP 6480464 Beclomethasone results in decreased expression of BGLAP protein CTD PMID:7746775 more ... benzo[a]pyrene decreases methylation EXP 6480464 Benzoapyrene results in decreased methylation of BGLAP promoter CTD PMID:27901495 berberine increases expression EXP 6480464 Berberine results in increased expression of BGLAP mRNA, Berberine results in increased expression of BGLAP protein CTD PMID:26478571 berberine multiple interactions EXP 6480464 CTNNB1 mutant form inhibits the reaction [Berberine results in increased expression of BGLAP protein], DKK1 protein inhibits the reaction [Berberine results in increased expression of BGLAP protein] CTD PMID:26478571 beta-D-glucosamine increases expression EXP 6480464 Glucosamine analog results in increased expression of BGLAP mRNA CTD PMID:20458730 bexarotene multiple interactions EXP 6480464 bexarotene inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA] CTD PMID:25932594 bisphenol A decreases expression ISO RGD:2206 6480464 bisphenol A results in decreased expression of BGLAP mRNA CTD PMID:27257137 Bisphenol A diglycidyl ether decreases expression ISO RGD:1621634 6480464 2, 2-bis4-glycidyloxyphenylpropane results in decreased expression of BGLAP mRNA CTD PMID:16972249 boron atom increases expression EXP 6480464 Boron results in increased expression of BGLAP mRNA CTD PMID:21625915 budesonide decreases expression EXP 6480464 Budesonide results in decreased expression of BGLAP protein CTD PMID:9232087 Butylparaben decreases expression ISO RGD:1621634 6480464 butylparaben results in decreased expression of BGLAP mRNA CTD PMID:28527915 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of BGLAP mRNA CTD PMID:20570719 cadmium atom decreases secretion EXP 6480464 Cadmium results in decreased secretion of BGLAP protein CTD PMID:31756223 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of BGLAP mRNA CTD PMID:20570719 cadmium dichloride decreases expression ISO RGD:2206 6480464 Cadmium Chloride results in decreased expression of BGLAP mRNA, Cadmium Chloride results in decreased expression of BGLAP protein CTD PMID:22209727 , PMID:22708652 cadmium dichloride multiple interactions ISO RGD:2206 6480464 [Cadmium Chloride co-treated with Plant Extracts] results in increased expression of BGLAP protein, [Cadmium Chloride co-treated with Polyphenols] results in increased expression of BGLAP protein CTD PMID:25656917 caesium atom decreases secretion ISO RGD:2206 6480464 Cesium results in decreased secretion of BGLAP protein CTD PMID:18797846 caffeine decreases expression ISO RGD:2206 6480464 Caffeine results in decreased expression of BGLAP mRNA CTD PMID:30423288 , PMID:31874197 calciol multiple interactions ISO RGD:1621634 6480464 [Tretinoin co-treated with Cholecalciferol] results in increased expression of BGLAP CTD PMID:17170073 calciol increases secretion EXP 6480464 Cholecalciferol results in increased secretion of BGLAP protein CTD PMID:17996099 calciol multiple interactions EXP 6480464 [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of BGLAP protein CTD PMID:17692823 calciol increases expression ISO RGD:2206 6480464 Cholecalciferol results in increased expression of BGLAP mRNA CTD PMID:19759027 calcitriol increases expression ISO RGD:1621634 6480464 Calcitriol results in increased expression of BGLAP mRNA CTD PMID:16889531 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of BGLAP mRNA CTD PMID:10470102 more ... calcitriol multiple interactions ISO RGD:2206 6480464 Aluminum inhibits the reaction [Calcitriol results in increased secretion of BGLAP protein], Calcitriol inhibits the reaction [Aluminum results in decreased secretion of BGLAP protein] CTD PMID:9626627 calcitriol decreases expression ISO RGD:1621634 6480464 Calcitriol results in decreased expression of BGLAP mRNA CTD PMID:17293108 calcitriol increases expression ISO RGD:2206 6480464 Calcitriol results in increased expression of BGLAP mRNA CTD PMID:16813520 calcitriol increases secretion EXP 6480464 Calcitriol results in increased secretion of BGLAP protein CTD PMID:12898515 calcitriol multiple interactions EXP 6480464 [Calcitriol co-treated with Alitretinoin] results in increased expression of BGLAP mRNA more ... CTD PMID:12898515 more ... calcium carbonate decreases expression EXP 6480464 Calcium Carbonate results in decreased expression of BGLAP protein CTD PMID:2027271 calcium dichloride increases expression EXP 6480464 Calcium Chloride results in increased expression of BGLAP mRNA CTD PMID:25824407 cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of BGLAP protein CTD PMID:32656944 CHIR 99021 increases expression ISO RGD:1621634 6480464 Chir 99021 results in increased expression of BGLAP mRNA CTD PMID:32220932 chitosan increases expression EXP 6480464 Chitosan results in increased expression of BGLAP mRNA CTD PMID:25246786 chlormequat chloride decreases expression ISO RGD:2206 6480464 Chlormequat results in decreased expression of BGLAP protein CTD PMID:28214531 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA] CTD PMID:23111315 cobalt dichloride increases expression ISO RGD:2206 6480464 cobaltous chloride results in increased expression of BGLAP mRNA, cobaltous chloride results in increased expression of BGLAP protein CTD PMID:26054564 , PMID:31472278 cobalt dichloride multiple interactions ISO RGD:2206 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of BGLAP protein] more ... CTD PMID:31472278 cobalt dichloride multiple interactions EXP 6480464 [cobaltous chloride co-treated with BMP2 protein] results in increased expression of BGLAP protein, cobaltous chloride affects the reaction [BMP2 protein results in increased expression of BGLAP mRNA] CTD PMID:26054564 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of BGLAP mRNA CTD PMID:19549813 corticosterone decreases expression ISO RGD:2206 6480464 Corticosterone results in decreased expression of BGLAP mRNA CTD PMID:30423288 corticosterone multiple interactions ISO RGD:2206 6480464 Enalapril inhibits the reaction [Corticosterone results in decreased expression of BGLAP mRNA] CTD PMID:30423288 cycloheximide multiple interactions ISO RGD:1621634 6480464 Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc Sulfate] results in increased expression of BGLAP mRNA], Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA] CTD PMID:17203194 daidzein multiple interactions EXP 6480464 [daidzein co-treated with ESR1 protein] results in increased expression of BGLAP mRNA, [daidzein co-treated with ESR2 protein] results in increased expression of BGLAP mRNA CTD PMID:19347870 dexamethasone multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA more ... CTD PMID:12510807 more ... dexamethasone multiple interactions ISO RGD:1621634 6480464 4-4-fluorophenyl-2-4-hydroxyphenyl-5-4-pyridylimidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP mRNA] more ... CTD PMID:26492236 more ... dexamethasone multiple interactions ISO RGD:2206 6480464 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of BGLAP mRNA more ... CTD PMID:19216230 more ... dexamethasone decreases expression ISO RGD:2206 6480464 Dexamethasone results in decreased expression of BGLAP protein CTD PMID:27387537 diarsenic trioxide multiple interactions ISO RGD:2206 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in decreased expression of BGLAP] CTD PMID:24531206 diarsenic trioxide decreases expression ISO RGD:2206 6480464 Arsenic Trioxide results in decreased expression of BGLAP, Arsenic Trioxide results in decreased expression of BGLAP mRNA CTD PMID:22465848 , PMID:24531206 disulfiram increases expression ISO RGD:2206 6480464 Disulfiram results in increased expression of BGLAP mRNA CTD PMID:24496638 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:23111315 , PMID:27188386 doxorubicin multiple interactions ISO RGD:2206 6480464 Quercetin inhibits the reaction [Doxorubicin results in increased expression of BGLAP protein], Vitamin E inhibits the reaction [Doxorubicin results in increased expression of BGLAP protein] CTD PMID:32810592 doxorubicin increases expression ISO RGD:2206 6480464 Doxorubicin results in increased expression of BGLAP protein CTD PMID:32810592 elemental boron increases expression EXP 6480464 Boron results in increased expression of BGLAP mRNA CTD PMID:21625915 enalapril multiple interactions ISO RGD:2206 6480464 Enalapril inhibits the reaction [Corticosterone results in decreased expression of BGLAP mRNA], Enalapril inhibits the reaction [Ethanol results in decreased expression of BGLAP mRNA] CTD PMID:30423288 , PMID:31887396 enzacamene increases expression ISO RGD:2206 6480464 enzacamene results in increased expression of BGLAP protein CTD PMID:15979666 ethanol multiple interactions ISO RGD:1621634 6480464 [Genistein co-treated with Ethanol] results in increased expression of BGLAP mRNA, Vitamin D affects the reaction [Ethanol results in decreased expression of BGLAP mRNA] CTD PMID:22892342 , PMID:24872432 ethanol decreases expression ISO RGD:1621634 6480464 Ethanol results in decreased expression of BGLAP mRNA, Ethanol results in decreased expression of BGLAP protein CTD PMID:22892342 ethanol decreases expression ISO RGD:2206 6480464 Ethanol results in decreased expression of BGLAP mRNA, Ethanol results in decreased expression of BGLAP protein CTD PMID:23376407 , PMID:31887396 ethanol multiple interactions ISO RGD:2206 6480464 Enalapril inhibits the reaction [Ethanol results in decreased expression of BGLAP mRNA], Ethanol promotes the reaction [lead acetate results in decreased expression of BGLAP protein] CTD PMID:23376407 , PMID:31887396 Falecalcitriol increases expression EXP 6480464 26 more ... CTD PMID:12016462 fasudil hydrochloride multiple interactions ISO RGD:1621634 6480464 4-4-fluorophenyl-2-4-hydroxyphenyl-5-4-pyridylimidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP mRNA] more ... CTD PMID:31935364 fentin hydroxide multiple interactions ISO RGD:1621634 6480464 triphenyltin hydroxide inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA] CTD PMID:32473317 flavonoids increases expression ISO RGD:2206 6480464 Flavonoids results in increased expression of BGLAP mRNA CTD PMID:23238999 fluticasone increases expression EXP 6480464 Fluticasone results in increased expression of BGLAP protein CTD PMID:11555383 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [Estradiol results in increased expression of BGLAP mRNA] more ... CTD PMID:17689939 , PMID:26362186 fulvestrant multiple interactions ISO RGD:2206 6480464 fulvestrant inhibits the reaction [naringin results in increased secretion of BGLAP protein] CTD PMID:23596885 gamma-aminobutyric acid affects expression ISO RGD:2206 6480464 gamma-Aminobutyric Acid affects the expression of BGLAP protein CTD PMID:24098073 gamma-Oryzanol (TN) affects expression ISO RGD:2206 6480464 gamma-oryzanol affects the expression of BGLAP protein CTD PMID:24098073 genistein multiple interactions ISO RGD:1621634 6480464 [Genistein co-treated with Ethanol] results in increased expression of BGLAP mRNA more ... CTD PMID:17203194 , PMID:24872432 genistein increases expression ISO RGD:1621634 6480464 Genistein results in increased expression of BGLAP mRNA CTD PMID:24872432 genistein multiple interactions EXP 6480464 [Genistein co-treated with ESR1 protein] results in increased expression of BGLAP mRNA, [Genistein co-treated with ESR2 protein] results in increased expression of BGLAP mRNA CTD PMID:19347870 glycerol 2-phosphate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA more ... CTD PMID:17692823 more ... glycerol 2-phosphate multiple interactions ISO RGD:1621634 6480464 4-4-fluorophenyl-2-4-hydroxyphenyl-5-4-pyridylimidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP mRNA] more ... CTD PMID:26492236 more ... glycerol 2-phosphate multiple interactions ISO RGD:2206 6480464 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of BGLAP mRNA more ... CTD PMID:27028516 glycyrrhetinate multiple interactions ISO RGD:1621634 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of BGLAP protein] more ... CTD PMID:21910061 glycyrrhetinic acid multiple interactions ISO RGD:1621634 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of BGLAP protein] more ... CTD PMID:21910061 Goserelin multiple interactions EXP 6480464 [Goserelin co-treated with kuntai capsule] affects the expression of BGLAP protein CTD PMID:25566615 hexadecanoic acid multiple interactions ISO RGD:2206 6480464 acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of BGLAP mRNA] more ... CTD PMID:24080574 hexadecanoic acid increases expression ISO RGD:2206 6480464 Palmitic Acid results in increased expression of BGLAP mRNA CTD PMID:24080574 hydrogen chloride increases expression EXP 6480464 Hydrochloric Acid results in increased expression of BGLAP CTD PMID:17183249 hydrogen peroxide multiple interactions EXP 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BGLAP mRNA] CTD PMID:25130202 hydrogen peroxide multiple interactions ISO RGD:2206 6480464 Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of BGLAP mRNA], Quercetin affects the reaction [Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of BGLAP mRNA]] CTD PMID:27028516 hydrogen peroxide decreases expression ISO RGD:1621634 6480464 Hydrogen Peroxide results in decreased expression of BGLAP mRNA, Hydrogen Peroxide results in decreased expression of BGLAP protein CTD PMID:20981859 , PMID:25130202 hydrogen peroxide multiple interactions ISO RGD:1621634 6480464 chrysoeriol inhibits the reaction [Hydrogen Peroxide results in decreased expression of BGLAP protein], myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BGLAP mRNA] CTD PMID:20981859 , PMID:25130202 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of BGLAP mRNA CTD PMID:25130202 icariin increases expression ISO RGD:1621634 6480464 icariin results in increased expression of BGLAP mRNA CTD PMID:18295595 icariin increases expression ISO RGD:2206 6480464 icariin results in increased expression of BGLAP mRNA CTD PMID:18236786 icariin multiple interactions ISO RGD:1621634 6480464 NOG protein inhibits the reaction [icariin results in increased expression of BGLAP mRNA], SMAD6 protein inhibits the reaction [icariin results in increased expression of BGLAP mRNA] CTD PMID:18295595 icariside II increases expression ISO RGD:2206 6480464 baohuoside I results in increased expression of BGLAP mRNA CTD PMID:17764702 ifosfamide decreases expression EXP 6480464 Ifosfamide results in decreased expression of BGLAP protein CTD PMID:1525342 ionomycin multiple interactions ISO RGD:1621634 6480464 Ionomycin affects the reaction [CALR protein affects the expression of BGLAP mRNA] CTD PMID:32220932 iron dextran decreases expression ISO RGD:2206 6480464 Iron-Dextran Complex results in decreased expression of BGLAP mRNA CTD PMID:29122540 isonicotinamide increases expression ISO RGD:2206 6480464 isonicotinamide results in increased expression of BGLAP mRNA CTD PMID:16813520 isonicotinamide increases expression EXP 6480464 isonicotinamide results in increased expression of BGLAP mRNA CTD PMID:21745208 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA more ... CTD PMID:12510807 more ... L-ascorbic acid multiple interactions ISO RGD:1621634 6480464 4-4-fluorophenyl-2-4-hydroxyphenyl-5-4-pyridylimidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP mRNA] more ... CTD PMID:26492236 more ... L-ascorbic acid multiple interactions ISO RGD:2206 6480464 [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of BGLAP mRNA more ... CTD PMID:27028516 L-ascorbic acid 2-phosphate multiple interactions EXP 6480464 [Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA more ... CTD PMID:23111315 lead diacetate decreases expression ISO RGD:2206 6480464 lead acetate results in decreased expression of BGLAP protein CTD PMID:23376407 lead diacetate multiple interactions ISO RGD:2206 6480464 Ethanol promotes the reaction [lead acetate results in decreased expression of BGLAP protein] CTD PMID:23376407 lead(0) decreases expression ISO RGD:2206 6480464 Lead results in decreased expression of BGLAP mRNA CTD PMID:23086611 lead(0) decreases secretion EXP 6480464 Lead results in decreased secretion of BGLAP protein CTD PMID:31756223 lead(0) decreases expression ISO RGD:1621634 6480464 Lead results in decreased expression of BGLAP mRNA CTD PMID:23086611 lead(2+) decreases expression ISO RGD:2206 6480464 Lead results in decreased expression of BGLAP mRNA CTD PMID:23086611 lead(2+) decreases secretion EXP 6480464 Lead results in decreased secretion of BGLAP protein CTD PMID:31756223 lead(2+) decreases expression ISO RGD:1621634 6480464 Lead results in decreased expression of BGLAP mRNA CTD PMID:23086611 levonorgestrel multiple interactions EXP 6480464 VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 lithium chloride affects expression EXP 6480464 Lithium Chloride affects the expression of BGLAP mRNA CTD PMID:30738844 lithium chloride multiple interactions EXP 6480464 Lithium Chloride affects the reaction [perfluorooctane sulfonic acid affects the expression of BGLAP mRNA] CTD PMID:30738844 lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of BGLAP mRNA CTD PMID:20055894 lithocholic acid multiple interactions EXP 6480464 Lithocholic Acid inhibits the reaction [Vitamin D results in increased expression of BGLAP mRNA] CTD PMID:20055894 magnesium atom increases expression EXP 6480464 Magnesium results in increased expression of BGLAP protein CTD PMID:10397942 melatonin increases expression EXP 6480464 Melatonin results in increased expression of BGLAP mRNA CTD PMID:20738756 menadione decreases expression EXP 6480464 Vitamin K 3 results in decreased expression of BGLAP mRNA CTD PMID:19675304 menadione increases expression ISO RGD:1621634 6480464 Vitamin K 3 results in increased expression of BGLAP protein modified form CTD PMID:30453296 menadione increases secretion ISO RGD:1621634 6480464 Vitamin K 3 results in increased secretion of BGLAP protein CTD PMID:30453296 menadione multiple interactions ISO RGD:1621634 6480464 Vitamin K 3 inhibits the reaction [Estrogens deficiency results in decreased secretion of BGLAP protein] CTD PMID:30453296 menaquinone decreases expression EXP 6480464 Vitamin K 2 results in decreased expression of BGLAP mRNA CTD PMID:19675304 menaquinone multiple interactions ISO RGD:2206 6480464 PTH protein promotes the reaction [Vitamin K 2 results in increased carboxylation of BGLAP protein] more ... CTD PMID:30639440 menaquinone increases secretion ISO RGD:2206 6480464 Vitamin K 2 results in increased secretion of BGLAP protein modified form CTD PMID:30639440 menaquinone multiple interactions EXP 6480464 Vitamin K 2 inhibits the reaction [IL1B protein results in decreased expression of BGLAP protein modified form] CTD PMID:20460758 menaquinone-7 increases carboxylation ISO RGD:1621634 6480464 vitamin MK 7 results in increased carboxylation of BGLAP protein CTD PMID:31173816 menaquinone-7 multiple interactions ISO RGD:1621634 6480464 Warfarin inhibits the reaction [vitamin MK 7 results in increased carboxylation of BGLAP protein] CTD PMID:31173816 menatetrenone increases expression ISO RGD:1621634 6480464 menatetrenone results in increased expression of BGLAP mRNA CTD PMID:11113387 menatetrenone multiple interactions ISO RGD:1621634 6480464 Warfarin inhibits the reaction [menatetrenone results in increased carboxylation of BGLAP protein] CTD PMID:31173816 menatetrenone increases carboxylation ISO RGD:1621634 6480464 menatetrenone results in increased carboxylation of BGLAP protein CTD PMID:31173816 methotrexate multiple interactions ISO RGD:2206 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of BGLAP mRNA CTD PMID:25187349 methylparaben decreases expression ISO RGD:1621634 6480464 methylparaben results in decreased expression of BGLAP mRNA CTD PMID:28527915 methylparaben multiple interactions ISO RGD:1621634 6480464 NR3C1 protein promotes the reaction [methylparaben results in decreased expression of BGLAP mRNA], PPARG protein promotes the reaction [methylparaben results in decreased expression of BGLAP mRNA] CTD PMID:28527915 montelukast increases expression ISO RGD:1621634 6480464 montelukast results in increased expression of BGLAP mRNA CTD PMID:19544365 myricitrin multiple interactions EXP 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BGLAP mRNA] CTD PMID:25130202 myricitrin multiple interactions ISO RGD:1621634 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BGLAP mRNA] CTD PMID:25130202 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:1621634 6480464 [zinc chloride co-treated with N more ... CTD PMID:19913120 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1621634 6480464 N more ... CTD PMID:22228435 naringin increases secretion ISO RGD:2206 6480464 naringin results in increased secretion of BGLAP protein CTD PMID:23596885 naringin multiple interactions ISO RGD:2206 6480464 fulvestrant inhibits the reaction [naringin results in increased secretion of BGLAP protein] CTD PMID:23596885 naringin increases expression ISO RGD:1621634 6480464 naringin results in increased expression of BGLAP mRNA, naringin results in increased expression of BGLAP protein CTD PMID:18495116 , PMID:21741227 naringin increases expression EXP 6480464 naringin results in increased expression of BGLAP mRNA, naringin results in increased expression of BGLAP protein CTD PMID:18495116 nebivolol multiple interactions ISO RGD:2206 6480464 [Nebivolol co-treated with Alendronate] inhibits the reaction [Methylprednisolone results in decreased secretion of BGLAP protein] CTD PMID:30291735 neoeriocitrin increases expression ISO RGD:1621634 6480464 neoeriocitrin results in increased expression of BGLAP mRNA CTD PMID:21741227 neoeriocitrin multiple interactions ISO RGD:1621634 6480464 neoeriocitrin inhibits the reaction [2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one results in decreased expression of BGLAP mRNA] CTD PMID:21741227 nicotine increases expression EXP 6480464 Nicotine results in increased expression of BGLAP CTD PMID:19436947 nicotine decreases expression ISO RGD:2206 6480464 Nicotine results in decreased expression of BGLAP mRNA CTD PMID:29981921 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of BGLAP CTD PMID:19436947 nicotine multiple interactions EXP 6480464 Tubocurarine inhibits the reaction [Nicotine results in increased expression of BGLAP] CTD PMID:19436947 nitric acid increases expression ISO RGD:2206 6480464 Nitric Acid results in increased expression of BGLAP protein CTD PMID:16436523 NMN zwitterion multiple interactions ISO RGD:1621634 6480464 Nicotinamide Mononucleotide inhibits the reaction [Aluminum Chloride results in decreased expression of BGLAP protein] CTD PMID:30292833 NMN zwitterion multiple interactions ISO RGD:2206 6480464 Nicotinamide Mononucleotide inhibits the reaction [Aluminum Chloride results in decreased activity of BGLAP protein], Nicotinamide Mononucleotide inhibits the reaction [Aluminum Chloride results in decreased expression of BGLAP protein] CTD PMID:30292833 norethisterone increases secretion EXP 6480464 Norethindrone results in increased secretion of BGLAP protein CTD PMID:8053399 notoginsenoside R1 multiple interactions EXP 6480464 fulvestrant inhibits the reaction [notoginsenoside R1 results in increased expression of BGLAP mRNA] CTD PMID:26362186 notoginsenoside R1 increases expression EXP 6480464 notoginsenoside R1 results in increased expression of BGLAP mRNA CTD PMID:26362186 ormeloxifene affects expression ISO RGD:2206 6480464 ormeloxifene affects the expression of BGLAP protein CTD PMID:15261309 oxaliplatin increases expression ISO RGD:2206 6480464 oxaliplatin results in increased expression of BGLAP mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:2206 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BGLAP mRNA CTD PMID:25729387 pamidronate increases expression EXP 6480464 pamidronate results in increased expression of BGLAP protein CTD PMID:11683535 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of BGLAP mRNA CTD PMID:29067470 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 DKK1 protein affects the reaction [perfluorooctane sulfonic acid affects the expression of BGLAP mRNA], Lithium Chloride affects the reaction [perfluorooctane sulfonic acid affects the expression of BGLAP mRNA] CTD PMID:30738844 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of BGLAP mRNA, perfluorooctane sulfonic acid affects the expression of BGLAP protein CTD PMID:30738844 Phenylamil increases expression EXP 6480464 phenylamil results in increased expression of BGLAP mRNA CTD PMID:24102669 phosphatidic acid increases activity EXP 6480464 Phosphatidic Acids results in increased activity of BGLAP protein CTD PMID:16857255 phylloquinone multiple interactions ISO RGD:1621634 6480464 Warfarin inhibits the reaction [Vitamin K 1 results in increased carboxylation of BGLAP protein] CTD PMID:31173816 phylloquinone increases carboxylation ISO RGD:1621634 6480464 Vitamin K 1 results in increased carboxylation of BGLAP protein CTD PMID:31173816 pioglitazone multiple interactions ISO RGD:1621634 6480464 Pioglitazone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA] CTD PMID:32473317 poly(ethylene) decreases expression EXP 6480464 Polyethylene results in decreased expression of BGLAP protein CTD PMID:10225790 prallethrin multiple interactions ISO RGD:1621634 6480464 d, d-T80-prallethrin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA] CTD PMID:32473317 quercetin decreases expression ISO RGD:2206 6480464 Quercetin results in decreased expression of BGLAP mRNA CTD PMID:14757127 quercetin multiple interactions ISO RGD:2206 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased expression of BGLAP mRNA] more ... CTD PMID:23117658 more ... quercetin increases expression EXP 6480464 Quercetin results in increased expression of BGLAP mRNA, Quercetin results in increased expression of BGLAP protein CTD PMID:24102669 quercetin multiple interactions EXP 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased expression of BGLAP protein] CTD PMID:24102669 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of BGLAP mRNA CTD PMID:21632981 quercetin increases expression ISO RGD:2206 6480464 Quercetin results in increased expression of BGLAP mRNA, Quercetin results in increased expression of BGLAP protein CTD PMID:26053266 , PMID:26136938 quinoxyfen multiple interactions ISO RGD:1621634 6480464 quinoxyfen inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA] CTD PMID:32473317 raloxifene decreases expression EXP 6480464 Raloxifene Hydrochloride results in decreased expression of BGLAP protein CTD PMID:17823083 resveratrol multiple interactions EXP 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased expression of BGLAP mRNA] more ... CTD PMID:16267019 , PMID:17689939 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of BGLAP mRNA CTD PMID:16267019 more ... resveratrol increases expression ISO RGD:2206 6480464 resveratrol results in increased expression of BGLAP mRNA, resveratrol results in increased expression of BGLAP protein CTD PMID:16813520 more ... rotenone increases expression EXP 6480464 Rotenone results in increased expression of BGLAP mRNA CTD PMID:29955902 SB 203580 multiple interactions ISO RGD:2206 6480464 [pyrazolanthrone co-treated with SB 203580 co-treated with 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one] inhibits the reaction [Quercetin results in increased expression of BGLAP protein] more ... CTD PMID:26136938 , PMID:31472278 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of BGLAP mRNA CTD PMID:27188386 sciadopitysin multiple interactions ISO RGD:1621634 6480464 sciadopitysin inhibits the reaction [Antimycin A results in increased expression of BGLAP protein] CTD PMID:23624148 sciadopitysin increases expression ISO RGD:1621634 6480464 sciadopitysin results in increased expression of BGLAP protein CTD PMID:23624148 simvastatin multiple interactions ISO RGD:1621634 6480464 CTNNB1 mutant form inhibits the reaction [Simvastatin results in increased expression of BGLAP protein], DKK1 inhibits the reaction [Simvastatin results in increased expression of BGLAP mRNA] CTD PMID:22058016 simvastatin increases expression ISO RGD:2206 6480464 Simvastatin results in increased expression of BGLAP protein CTD PMID:19292885 simvastatin multiple interactions ISO RGD:2206 6480464 [Simvastatin co-treated with Dexamethasone] results in increased expression of BGLAP CTD PMID:19216230 simvastatin increases secretion EXP 6480464 Simvastatin results in increased secretion of BGLAP protein CTD PMID:20381859 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of BGLAP, Simvastatin results in increased expression of BGLAP mRNA CTD PMID:15953866 more ... simvastatin increases expression ISO RGD:1621634 6480464 Simvastatin results in increased expression of BGLAP more ... CTD PMID:12914771 more ... sirolimus multiple interactions EXP 6480464 Sirolimus inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA] CTD PMID:23111315 sodium arsenite decreases expression ISO RGD:1621634 6480464 sodium arsenite results in decreased expression of BGLAP mRNA CTD PMID:28206643 sodium fluoride affects expression ISO RGD:2206 6480464 Sodium Fluoride affects the expression of BGLAP mRNA CTD PMID:25132241 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of BGLAP protein CTD PMID:30259626 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of BGLAP mRNA CTD PMID:26339601 streptozocin decreases expression ISO RGD:2206 6480464 Streptozocin results in decreased expression of BGLAP mRNA, Streptozocin results in decreased expression of BGLAP protein CTD PMID:25617479 streptozocin multiple interactions ISO RGD:2206 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of BGLAP protein modified form, Warfarin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of BGLAP protein modified form] CTD PMID:27488359 sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of BGLAP mRNA CTD PMID:31533062 tamoxifen multiple interactions EXP 6480464 [Tamoxifen co-treated with ESR1 protein] results in increased expression of BGLAP mRNA CTD PMID:19347870 tetrachloromethane decreases expression ISO RGD:2206 6480464 Carbon Tetrachloride results in decreased expression of BGLAP protein CTD PMID:12631673 titanium atom increases expression ISO RGD:2206 6480464 Titanium results in increased expression of BGLAP mRNA CTD PMID:15914587 topotecan multiple interactions ISO RGD:2206 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BGLAP mRNA CTD PMID:25729387 tributylstannane multiple interactions ISO RGD:1621634 6480464 tributyltin promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of BGLAP mRNA] CTD PMID:22749964 tributylstannane multiple interactions EXP 6480464 tributyltin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA] CTD PMID:25932594 tributylstannane increases expression ISO RGD:1621634 6480464 tributyltin results in increased expression of BGLAP mRNA CTD PMID:22749964 troglitazone decreases expression ISO RGD:2206 6480464 troglitazone results in decreased expression of BGLAP mRNA CTD PMID:16813520 tubocurarine multiple interactions EXP 6480464 Tubocurarine inhibits the reaction [Nicotine results in increased expression of BGLAP] CTD PMID:19436947 tungsten decreases expression ISO RGD:1621634 6480464 Tungsten results in decreased expression of BGLAP mRNA CTD PMID:26865663 uranium atom increases expression ISO RGD:2206 6480464 Uranium results in increased expression of BGLAP protein CTD PMID:16436523 uranium atom multiple interactions ISO RGD:2206 6480464 GHRL protein inhibits the reaction [Uranium results in decreased secretion of BGLAP protein] CTD PMID:29477364 uranium atom decreases secretion ISO RGD:2206 6480464 Uranium results in decreased secretion of BGLAP protein CTD PMID:29477364 uranium atom increases expression ISO RGD:1621634 6480464 Uranium results in increased expression of BGLAP mRNA CTD PMID:31120128 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of BGLAP mRNA CTD PMID:24383497 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of BGLAP mRNA CTD PMID:27188386 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of BGLAP mRNA CTD PMID:25979313 vitamin D multiple interactions EXP 6480464 Lithocholic Acid inhibits the reaction [Vitamin D results in increased expression of BGLAP mRNA] CTD PMID:20055894 vitamin D multiple interactions ISO RGD:1621634 6480464 Vitamin D affects the reaction [Ethanol results in decreased expression of BGLAP mRNA] CTD PMID:22892342 vitamin D increases expression EXP 6480464 Vitamin D results in increased expression of BGLAP mRNA CTD PMID:20055894 vitamin E multiple interactions ISO RGD:2206 6480464 Vitamin E inhibits the reaction [Doxorubicin results in increased expression of BGLAP protein] CTD PMID:32810592 vitamin K multiple interactions ISO RGD:2206 6480464 [Warfarin co-treated with Vitamin K] results in increased expression of BGLAP mRNA, Quercetin inhibits the reaction [[Warfarin co-treated with Vitamin K] results in increased expression of BGLAP mRNA] CTD PMID:23117658 vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of BGLAP mRNA CTD PMID:27188386 warfarin multiple interactions ISO RGD:1621634 6480464 Warfarin inhibits the reaction [BMP2 protein results in increased activity of BGLAP protein] more ... CTD PMID:21910061 , PMID:31173816 warfarin increases expression ISO RGD:2206 6480464 Warfarin results in increased expression of BGLAP mRNA, Warfarin results in increased expression of BGLAP protein modified form CTD PMID:23223575 , PMID:27488359 warfarin multiple interactions ISO RGD:2206 6480464 [Warfarin co-treated with Vitamin K] results in increased expression of BGLAP mRNA more ... CTD PMID:23117658 more ... zinc atom decreases expression ISO RGD:1621634 6480464 Zinc results in decreased expression of BGLAP protein CTD PMID:22228435 zinc atom decreases expression ISO RGD:2206 6480464 Zinc deficiency results in decreased expression of BGLAP mRNA, Zinc deficiency results in decreased expression of BGLAP protein CTD PMID:21893222 zinc atom multiple interactions ISO RGD:1621634 6480464 [Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA, Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA] CTD PMID:17203194 zinc dichloride multiple interactions ISO RGD:1621634 6480464 [zinc chloride co-treated with N more ... CTD PMID:19913120 zinc sulfate multiple interactions ISO RGD:1621634 6480464 [Genistein co-treated with Zinc Sulfate] results in increased expression of BGLAP mRNA, Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc Sulfate] results in increased expression of BGLAP mRNA] CTD PMID:17203194 zinc(0) multiple interactions ISO RGD:1621634 6480464 [Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA, Cycloheximide inhibits the reaction [[Genistein co-treated with Zinc] results in increased expression of BGLAP mRNA] CTD PMID:17203194 zinc(0) decreases expression ISO RGD:1621634 6480464 Zinc results in decreased expression of BGLAP protein CTD PMID:22228435 zinc(0) decreases expression ISO RGD:2206 6480464 Zinc deficiency results in decreased expression of BGLAP mRNA, Zinc deficiency results in decreased expression of BGLAP protein CTD PMID:21893222 zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of BGLAP mRNA CTD PMID:14751568